Using speech to measure cognitive changes in clinical trials and research studies
A 10-minute phone call measures cognitive impairment automatically and remotely
V3 guided, clinically proven
Validation based on large cohorts across Europe following approved methodology from the V3 framework of the Digital Medicine Society (DiME)
- Distinction of clinical groups
- Analytical validation evidence
- Clinical validation evidence


Check out our new validation results on remote speech biomarker for cognition (SB-C) in early Alzheimer’s disease
Tröger J, Baykara E, Zhao J, ter Huurne D, Possemis N, Mallick E, Schäfer S, Schwed L, Mina M, Linz N, Ramakers I, Ritchie C: Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 Framework. Digit Biomark 2022;6:107-116. doi: 10.1159/000526471
Cutting-edge technology for real-world solutions
The biomarker can be deployed in any study e.g. using ki:elements mili platform
A patient's view on the remote assessment
Usability study for automated and semi-automated testing over the phone
How comfortable do you feel about completing the tasks at home?
How comfortable do you feel about completing the tasks on the phone?
Ongoing collaborations on SB-C
We work with a number of KOLs
n~2000 – Prodromal AD/MCI
n~300 – Pre-clinical AD
n~250 – Prodromal AD/MCI
n~300 – Pre-clinical AD
n~300 – Pre-clinical AD
n~250 – All-comer
Use SB-C in your study!
Get in touch
We’re looking forward to working with you! SB-C is deployed via our Mili platform into clinical studies and trials. If you are interested in deploying it in your study, please reach out to us.
Academic groups wanting to use the technology can partner with us to receive reduced licensing costs.